WOW. John Owen

W. John Owen

*This is an algorithmically generated author record based on publicly available information.

W. John Owen has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Chenglin Yao

    Crop Protection Discovery Biology, Corteva Agriscience™, Agriculture Division of DowDuPont, Indianapolis, IN, USA

    4 shared publications
  • Kevin G Meyer

    Crop Protection Discovery Chemistry, Corteva Agriscience™, Agriculture Division of DowDuPont, Indianapolis, IN, USA

    2 shared publications
  • Kevin G. Meyer

    Dow AgroSciences LLC, Crop Protection Discovery Chemistry, Indianapolis, IN, USA

    2 shared publications
  • Nick X. Wang

    Dow AgroSciences LLC, Crop Protection Discovery Chemistry, Indianapolis, IN, USA

    2 shared publications
  • Stacy T. Meyer

    Dow AgroSciences LLC, Crop Protection Discovery Biology, Indianapolis, IN, USA

    2 shared publications
  • Thomas J. Slanec

    Dow AgroSciences LLC, Crop Protection Discovery Biology, Indianapolis, IN, USA

    2 shared publications

Latest Publications

  • Synthesis and biological activity of analogs of the antifungal antibiotic UK‐2A. III. Impact of modifications to the macrocycle isobutyryl ester position

    by W John Owen, Kevin G Meyer, Thomas J Slanec, Stacy T Meyer, Nick X Wang, Gina M Fitzpatrick, Noormohamed N Niyaz, Jaime Nugent, Michael J Ricks, Richard B Rogers, et al.

    BACKGROUND: Fenpicoxamid (Inatreq™ active), a new fungicide under development by Corteva Agriscience™, Agriculture Division of DowDuPont, is an isobutyryl acetal derivative of the antifungal antibiotic UK‐2A. SAR studies around the picolinamide ring and benzyl substituents attached at positions 3 and 8, respectively, of the UK‐2A bislactone macrocycle have recently been documented. This study focuses on replacement of the isobutyryl ester group in the 7 position.RESULTS: Thirty analogs, predominantly esters and ethers, were prepared and evaluated for inhibition of mitochondrial electron transport and in vitro growth of Zymoseptoria tritici, Leptosphaeria nodorum, Pyricularia oryzae and Ustilago maydis. Aliphatic substituents containing four to six carbon atoms deliver strong intrinsic activity, the pivaloate ester (IC50 1.44 nM) and the n‐butyl, 1‐Me‐propyl, 3,3‐diMe‐propyl and 2‐c‐propyl propyl ethers (IC50 values = 1.08, 1.14, 1.15 & 1.32 nM, respectively) being the most active derivatives. QSAR modelling identified solvation energy (Esolv) and critical packing parameters (vsurf_CP) as highly significant molecular descriptors for explaining relative intrinsic activity of analogs. Activity translation to fungal growth inhibition and disease control testing was significantly influenced by intrinsic activity and physical properties, the cyclopropanecarboxylate ester (log D 3.67, IC50 3.36 nM, Z. tritici EC50 12 μg L−1) showing the strongest Z. tritici activity in protectant tests.CONCLUSIONS: Substitution of the isobutyryl ester group of UK‐2A generates analogs that retain strong antifungal activity against Z. tritici and other fungi. © 2019 Society of Chemical Industry


  • Synthesis and biological activity of analogs of the antifungal antibiotic UK‐2A. II. Impact of modifications to the macrocycle benzyl position

    by W. John Owen, Kevin G. Meyer, Stacy T. Meyer, Fangzheng Li, Thomas J. Slanec, Nick X. Wang, Chenglin Yao

    BACKGROUND: UK‐2A is an antifungal antibiotic produced by Streptomyces sp. 517‐02. Derivatization of its picolinamide OH to form the isobutyryl acetal led to the discovery of fenpicoxamid (InatreqTM active), which is currently under development as a fungicide by Dow AgroSciences LLC. This paper documents efforts to achieve additional efficacy enhancements through semi‐synthetic modification of the benzyl substituent of the UK‐2A macrocycle.RESULTS: Of 34 analogs prepared, the most active had mitochondrial electron transport IC50 values 1.5‐ to 3.7‐fold higher than UK‐2A (IC50 0.86 nM). The cyclohexyl analog (38, IC50 1.23 nM) was the most intrinsically active derivative, and inhibited in vitro growth of Zymoseptoria tritici (EC50 2.8 ppb) and Leptosphaeria nodorum (EC50 6.2 ppb) more strongly than UK‐2A (EC50 5.3 and 11.3 ppb for Z. tritici and L. nodorum, respectively). Heterocyclic ring systems and polar linker functionalities resulted in substantial activity loss. Several analogs (20, 22, 23, 24, 36 and 38) translated Z. tritici in vitro growth inhibition activity to in planta disease control more effectively than did UK‐2A, with log D being a key factor in this regard.CONCLUSIONS: UK‐2A is amenable to further modification at the benzyl position on the macrocycle, which provides opportunities for manipulation of physical properties while retaining strong intrinsic and antifungal activity. © 2019 Society of Chemical Industry


  • Synthesis and biological activity of analogs of the antifungal antibiotic UK‐2A. I. Impact of picolinamide ring replacement

    by W. John Owen, Kevin G. Meyer, Thomas J. Slanec, Nick X. Wang, Stacy T. Meyer, Noormohamed M. Niyaz, Richard B. Rogers, Karla Bravo‐Altamirano, Jessica L. Herrick, Chenglin Yao

    BACKGROUND: The antifungal antibiotic UK‐2A strongly inhibits mitochondrial electron transport at the Qi site of the cytochrome bc1 complex. Previous reports have described semi‐synthetic modifications of UK‐2A to explore the structure–activity relationship (SAR), but efforts to replace the picolinic acid moiety have been limited.RESULTS: Nineteen UK‐2A analogs were prepared and evaluated for Qi site (cytochrome c reductase) inhibition and antifungal activity. While the majority are weaker Qi site inhibitors than UK‐2A (IC50, 3.8 nM), compounds 2, 5, 13 and 16 are slightly more active (IC50, 3.3, 2.02, 2.89 and 1.55 nM, respectively). Compared to UK‐2A, compounds 13 and 16 also inhibit growth of Zymoseptoria tritici and Leptosphaeria nodorum more strongly, while 2 and 13 provide stronger control of Z. tritici and Puccinia triticina in glasshouse tests. The relative activities of compounds 1‐19 are rationalized based on a homology model constructed for the Z. tritici Qi binding site. Physical properties of compounds 1‐19 influence translation of intrinsic activity to antifungal growth inhibition and in planta disease control.CONCLUSIONS: The 3‐hydroxy‐4‐methoxy picolinic acid moiety of UK‐2A can be replaced by a variety of o‐hydroxy‐substituted arylcarboxylic acids that retain strong activity against Z. tritici and other agriculturally relevant fungi. © 2018 Society of Chemical Industry


  • Open Access

    Biological characterization of fenpicoxamid, a new fungicide with utility in cereals and other crops

    by W John Owen, Chenglin Yao, Kyung Myung, Greg Kemmitt, Andrew Leader, Kevin G Meyer, Andrew J Bowling, Thomas Slanec, Vincent J Kramer

    BACKGROUND: The development of novel highly efficacious fungicides that lack cross‐resistance is extremely desirable. Fenpicoxamid (Inatreq™ active) possesses these characteristics and is a member of a novel picolinamide class of fungicides derived from the antifungal natural product UK‐2A.RESULTS: Fenpicoxamid strongly inhibited in vitro growth of several ascomycete fungi, including Zymoseptoria tritici (EC50, 0.051 mg L−1). Fenpicoxamid is converted by Z. tritici to UK‐2A, a 15‐fold stronger inhibitor of Z. tritici growth (EC50, 0.0033 mg L−1). Strong fungicidal activity of fenpicoxamid against driver cereal diseases was confirmed in greenhouse tests, where activity on Z. tritici and Puccinia triticina matched that of fluxapyroxad. Due to its novel target site (Qi site of the respiratory cyt bc1 complex) for the cereals market, fenpicoxamid is not cross‐resistant to Z. tritici isolates resistant to strobilurin and/or azole fungicides. Across multiple European field trials Z. tritici was strongly controlled (mean, 82%) by 100 g as ha−1 applications of fenpicoxamid, which demonstrated excellent residual activity.CONCLUSIONS: The novel chemistry and biochemical target site of fenpicoxamid as well as its lack of cross‐resistance and strong efficacy against Z. tritici and other pathogens highlight the importance of fenpicoxamid as a new tool for controlling plant pathogenic fungi. © 2017 The Authors. Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.